Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 November 2023 | Story André Damons | Photo SUPPLIED
SDG Competition 2023
From left: Dr Brandon van Rooyen, Dr Anathi Makamane, Dr Yolandi Schoeman and Daniel Naudé participated and won the SDG Challenge South Africa. Pieter Bruwer is absent from the photo.

A team of exceptional students from the University of the Free State (UFS) has claimed victory in the prestigious SDG Challenge South Africa, a global competition that unites students and organisations to address the United Nations Sustainable Development Goals (UNSDGs). This remarkable achievement not only underscores the skill and dedication of UFS students but also reinforces their commitment to forging a more sustainable and equitable world.

The group of students from different disciplines within the Faculty of Natural and Agricultural Sciences (NAS), came up with an interdisciplinary and forward-thinking approach which contributed significantly to their victory. The team members, including Pieter Bruwer, Dr Anathi Makamane, Dr Brandon van Rooyen (all from Sustainable Food Systems and Development), Daniel Naudé (Department of Agriculture Economics), as well as Dr Yolandi Schoeman (a postdoctoral fellow in the Centre for Environmental Management (CEM) from the Faculty of Natural and Agricultural Sciences, each brought their unique expertise to the challenge.

Prof Jan Willem Swanepoel, Associate Professor in the Department of Sustainable Food Systems and Development within the Faculty of Natural and Agricultural Sciences, provided invaluable mentorship to the team. The students were also supported by Robyn Mellett from OMI Solutions.

Dr Schoeman says the SDG Challenge, designed to confront global challenges, connects students and organisations from across the globe, fostering collaboration towards achieving the UNSDGs, which encompass critical issues such as climate change and the reduction of global inequalities. Teams from South African universities, including the University of Cape Town, Stellenbosch University, and the University of KwaZulu-Natal, partnered with leading companies to address specific challenges tied to their corporate missions.

Develop a waste management strategy

Team UFS joined forces with Ivanhoe Mines, a prominent mining company operating in the Democratic Republic of Congo to develop a waste management strategy for the Kamoa-Kakula Copper Complex. This endeavour was laden with complexities due to the limited waste management options available in the area. The challenge was not just about managing multiple waste streams from the mining complex, but also about addressing socioeconomic and biodiversity challenges stemming from the burgeoning population in the region, which led to a range of environmental concerns.

“In response, the UFS team innovatively conceived ÉcoFlotille, a solution that not only tackled essential waste management issues but also promoted biodiversity net gain. The plan extended its reach to support local agribusinesses and small and micro-enterprises through the repurposing and reuse of waste materials, while presenting a unique biofinancing opportunity. The EcoFlotille solution represents a distinctive aspect of their triumphant journey.

“ÉcoFlotille not only aligns with the SDGs but also plays a crucial role in realising the vision of the Kunming-Montreal Global Biodiversity Framework, which emphasises the conservation and sustainable use of biodiversity. Additionally, it aligns with the goals of Agenda 2063 for Africa, striving to advance the continent’s development objectives and create a prosperous and harmonious future for the region,” says Dr Schoeman. 

The scalability of ÉcoFlotille across Africa holds great promise. Its innovative waste management approach and biofinancing potential could serve as a model for addressing similar challenges in diverse regions of the continent. This opens up opportunities for wider adoption and positive impacts throughout Africa.

Creating a more sustainable and equitable world

The SDG Challenge South Africa is an integral part of Soapbox’s global mission to mobilise university students and organisations in working collaboratively toward the UNSDG. These goals aim to address the world’s most pressing challenges, requiring collective efforts to achieve sustainable economic growth, environmental sustainability, and social inclusion by 2030.

The UFS’s remarkable success in the SDG Challenge not only highlights the university’s dedication to fostering global citizenship and sustainability but also underscores the remarkable potential of its students in driving positive change in Africa and the world.

According to Dr Schoeman, the UFS team’s victory in the SDG Challenge stands as a testament to their unwavering commitment to creating a more sustainable and equitable world. Their innovative solution, ÉcoFlotille, serves as a beacon of hope, illustrating how the vigour and ingenuity of the younger generation can propel us closer to realising the UNSDG by 2030, effectively ticking all 17 SDG boxes.

Solving a real-world problem

Prof Swanepoel says the SDG Challenge is a global competition that unites students and organisations to address the UNSDGs. These goals encompass some of the most pressing challenges facing our world today, such as climate change, poverty, and inequality.

According to him, by participating in the SDG Challenge, the UFS students had the opportunity to apply their knowledge and skills to solve a real-world problem experienced by one of the biggest mining houses in the world. They gained valuable experience in collaborating with the private sector.

“I am immensely proud of the students' achievement in the prestigious Soapbox SDG Challenge South Africa. Their interdisciplinary approach and forward-thinking mindset are a testament to the calibre of education and mentorship they receive at the UFS,” Prof Swanepoel says. 

“Furthermore, I am confident that the skills and experience gained through the SDG Challenge will help the students to make a positive impact on the world. They are the next generation of leaders who will be responsible for addressing the complex social and environmental challenges Africa face. I also believe that coming out as victors in this competition would open more doors for them and the university in the private sector.”

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept